Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Caitlin E. Cox

January 30, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Conference News

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

L.A. McKeown

November 15, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Todd Neale

June 23, 2021

News Daily News

FDA Approves Dabigatran for VTE in Children

Shelley Wood

June 22, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Industry News

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

October 26, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Caitlin E. Cox

July 24, 2020

Advertisement

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

November 2024 Dispatch for the CV Team

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

October 2023 News Roundup

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

PAD Significantly Ups Morbidity and Mortality in AMICS

FDA Approves Two Additional Indications for Rivaroxaban in Children

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

AXIOMATIC-TKR: Milvexian Promising for VTE Prevention

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

FDA Approves Dabigatran for VTE in Children

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

COVID-19 Clots Spur Both Arterial, Venous Events in Hospitalized Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content